From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease
Swiss Archives of Neurology, Psychiatry and Psychotherapy · 2026
DOI: 10.3390/sanpp176030016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Swiss Archives of Neurology, Psychiatry and Psychotherapy, 2026. Verfasst von Paul G. Unschuld. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
For decades, clinicians treating Alzheimer’s disease could offer accurate diagnosis, symptomatic drugs, and compassionate support, but nothing that altered the course of the disease [...]
Zitieren
APA
Unschuld, P. G. (2026). From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease. Swiss Archives of Neurology, Psychiatry and Psychotherapy. https://doi.org/10.3390/sanpp176030016
Vancouver
Unschuld PG. From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease. Swiss Archives of Neurology, Psychiatry and Psychotherapy. 2026. doi:10.3390/sanpp176030016
BibTeX
@article{Unschuld2026,
author = {Unschuld, Paul G.},
title = {From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease},
journal = {Swiss Archives of Neurology, Psychiatry and Psychotherapy},
year = {2026},
doi = {10.3390/sanpp176030016}
}
EUVIMED